Harpoon Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Harpoon Therapeutics Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11115
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:27
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Harpoon Therapeutics Inc (Harpoon Therapeutics) is a biotechnology company that offers solutions for immune-oncology diseases. The company provides products portfolio such as of HPN424, prostate specific antigen and harnesses a technology named TriTAC technology. It employs TriTAC technology, a drug discovery platform used to engage T cell which helps to develop novel drugs for the treatment of cancer and other immune diseases. Harpoon Therapeutics technology platform also enables to treat solid tumor malignancies, blood cancers, viral infections, and other severe diseases such as acute and chronic inflammation. The company operates in the US. Harpoon Therapeutics is headquartered in South San Francisco, California, the US.

Harpoon Therapeutics Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Harpoon Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Harpoon Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Harpoon Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Harpoon Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Harpoon Therapeutics Inc, Medical Devices Deals, 2012 to YTD 2018 9
Harpoon Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Harpoon Therapeutics Inc, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Harpoon Therapeutics Raises USD70 Million in Series C Financing 11
Harpoon Therapeutics Raises USD45 Million in series B Financing 13
Harpoon Therapeutics Raises Funds through Venture Financing 15
Partnerships 16
CMC ICOS Biologics Enters into Co-development Agreement with Harpoon Therapeutics 16
AbbVie and Harpoon Therapeutics Enter into Research Partnership 17
Licensing Agreements 18
Harpoon Therapeutics Renews Licensing Agreement with Isogenica 18
Harpoon Therapeutics Inc – Key Competitors 19
Harpoon Therapeutics Inc – Key Employees 20
Harpoon Therapeutics Inc – Locations And Subsidiaries 21
Head Office 21
Recent Developments 22
Corporate Communications 22
Oct 30, 2018: Harpoon Therapeutics announces appointment of Ms. Georgia L. Erbez to Chief Financial officer and promotion of Holger Wesche, PhD, to Chief Scientific Officer 22
Oct 03, 2018: Harpoon Therapeutics names Natalie R. Sacks, M.D. as Chief Medical Officer 23
Sep 18, 2018: Harpoon Therapeutics appoints Jonathan Drachman as Board Director and Chris Whitmore as Vice President of Finance 24
Oct 26, 2017: Harpoon Therapeutics Expands Management Team 25
Jan 26, 2017: Harpoon Therapeutics Appoints William E. Picht, Jr. as Chief Financial Officer 26
Appendix 27
Methodology 27
About GlobalData 27
Contact Us 27
Disclaimer 27

List of Tables
Harpoon Therapeutics Inc, Pharmaceuticals & Healthcare, Key Facts 2
Harpoon Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Harpoon Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Harpoon Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Harpoon Therapeutics Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Harpoon Therapeutics Inc, Medical Devices Deals, 2012 to YTD 2018 9
Harpoon Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Harpoon Therapeutics Raises USD70 Million in Series C Financing 11
Harpoon Therapeutics Raises USD45 Million in series B Financing 13
Harpoon Therapeutics Raises Funds through Venture Financing 15
CMC ICOS Biologics Enters into Co-development Agreement with Harpoon Therapeutics 16
AbbVie and Harpoon Therapeutics Enter into Research Partnership 17
Harpoon Therapeutics Renews Licensing Agreement with Isogenica 18
Harpoon Therapeutics Inc, Key Competitors 19
Harpoon Therapeutics Inc, Key Employees 20

List of Figures
Harpoon Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Harpoon Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Harpoon Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Harpoon Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Harpoon Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Harpoon Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Harpoon Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Harpoon Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Harpoon Therapeutics Inc, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Harpoon Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • BioSyent Inc (RX):企業の財務・戦略的SWOT分析
    Summary BioSyent Inc (BioSyent), formerly Hedley Technologies Inc is a specialty pharmaceutical company that offers in-licensing or acquiring innovative pharmaceutical products and technologies to enhance human health. The company’s products include Aguettant System for pre-filled syringes, FeraMAX …
  • The Andersons Inc (ANDE):企業の財務・戦略的SWOT分析
    The Andersons Inc (ANDE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Pick n Pay Stores Limited:企業の戦略・SWOT・財務情報
    Pick n Pay Stores Limited - Strategy, SWOT and Corporate Finance Report Summary Pick n Pay Stores Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • PayPal Holdings, Inc.:企業のM&A・事業提携・投資動向
    PayPal Holdings, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's PayPal Holdings, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M …
  • The Toro Company:企業の戦略・SWOT・財務情報
    The Toro Company - Strategy, SWOT and Corporate Finance Report Summary The Toro Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Reliance Industries Limited:企業の戦略・SWOT・財務分析
    Reliance Industries Limited - Strategy, SWOT and Corporate Finance Report Summary Reliance Industries Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • TOWER Limited:企業の戦略・SWOT・財務分析
    TOWER Limited - Strategy, SWOT and Corporate Finance Report Summary TOWER Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • NIKE Inc:企業のM&A・事業提携・投資動向
    NIKE Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's NIKE Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital …
  • Debiopharm Innovation Fund SA:製薬・医療:M&Aディール及び事業提携情報
    Summary Debiopharm Innovation Fund SA (Debiopharm Innovation), formerly Debiopharm Diagnostics SA, a subsidiary of Debiopharm Group, is a patient care investment company that offers drug investments and development stage diagnostic solutions. The company offers investments for drugs on cancer severi …
  • Asseco Business Solutions SA (ABS):企業の財務・戦略的SWOT分析
    Asseco Business Solutions SA (ABS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Peako Ltd (PKO):石油・ガス:M&Aディール及び事業提携情報
    Summary Peako Ltd (Peako), formerly Peak Oil & Gas Ltd, is an oil and gas, and mineral exploration company. The company carries out the business of acquisition, exploration, and development of oil, natural gas, petroleum, and uranium properties. Its projects include SC6C Cadlao and Sunday Creek proj …
  • Concord Medical Services Holdings Ltd (CCM):企業の財務・戦略的SWOT分析
    Summary Concord Medical Services Holdings Ltd (CMS) is a diagnostic imaging center that offers clinical support services and laboratory services. The center offers radiotherapy and diagnostic imaging equipment services such as head gamma knife systems, body gamma knife systems and linear accelerator …
  • H. Lundbeck AS (LUN):企業の財務・戦略的SWOT分析
    H. Lundbeck AS (LUN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Stryker Corp (SYK):企業の財務・戦略的SWOT分析
    Stryker Corp (SYK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Blount International, Inc.:企業の戦略的SWOT分析
    Blount International, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • ET Solar Group Corporation:企業の戦略的SWOT分析
    ET Solar Group Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • NovoCure Ltd (NVCR)-医療機器分野:企業M&A・提携分析
    Summary NovoCure Ltd (NovoCure) is an drug company that concentrates on the development and commercialization of novel therapies for tumor treating fields. The company’s pipeline products find application in various types of cancer indications such as ovarian cancer, malignant melanoma, hepatocellul …
  • Sisaf Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Sisaf Ltd (Sisaf) is a drug delivery company which designs and develops topical delivery systems for cosmetic, medical, and skin care applications. The company manufactures and markets products and drug delivery solutions using ProSilic, a nano-silicon technology platform. It offers ProSilli …
  • Truman Arnold Companies, Inc.:企業の戦略・SWOT・財務分析
    Truman Arnold Companies, Inc. - Strategy, SWOT and Corporate Finance Report Summary Truman Arnold Companies, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Gridsum Holding, Inc. (GSUM):企業の財務・戦略的SWOT分析
    Gridsum Holding, Inc. (GSUM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆